Genetic variation in IL28B and treatment-induced clearance of hepatitis C virus in HIV-positive patients with acute and chronic hepatitis C

Jacob Nattermann, Martin Vogel, Hans Dieter Nischalke, Mark Danta, Stefan Mauss, Hans Jörg Stellbrink, Axel Baumgarten, Christoph Mayr, Raffaele Bruno, Cristina Tural, Gerd Klausen, Bonaventura Clotet, Uwe Naumann, Thomas Lutz, Michael Rausch, Knud Schewe, Bernhard Bienek, Georg Haerter, Tilman Sauerbruch, Juergen K. RockstrohUlrich Spengler

Research output: Contribution to journalArticleResearchpeer-review

52 Citations (Scopus)

Abstract

Recently, a IL28B (rs 12979860) gene polymorphism was identified as a predictor for response to hepatits C virus-specific treatment in human immunodeficiency virus (HIV)-uninfected and -infected patients with chronic hepatitis C. In an analysis of HIV-infected patients with acute hepatitis C, we found that the IL28B genotype was associated with serum levels of hepatitis C virus RNA, g-GT, and CD4 cell count. In contrast to HIV-infected patients with chronic hepatitis C, the IL28B genotype was not significantly associated with treatment response rates in patients with acute hepatitis C. Thus, effects of the IL28B single-nucleotide polymorphism may differ in HIV-infected patients with chronic and acute hepatitis C. © The Author 2011. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved.
Original languageEnglish
Pages (from-to)595-601
JournalJournal of Infectious Diseases
Volume203
Issue number5
DOIs
Publication statusPublished - 1 Mar 2011

Fingerprint Dive into the research topics of 'Genetic variation in IL28B and treatment-induced clearance of hepatitis C virus in HIV-positive patients with acute and chronic hepatitis C'. Together they form a unique fingerprint.

Cite this